Overexposure to environmental stress like pollution, smoke, harsh
weather and sun rays can accelerate skin ageing by triggering
oxidative stress in the skin.
To protect your skin against environmental stress Evonik launches TEGO® Cistus which will be presented at the IFSCC Congress 2012. This latest active is a standardized plant extract highly enriched in polyphenols from pink rock rose.
Cistus incanus spp. tauricus growths in Europe and parts of the Middle East and has a historical use in traditional European medicine.
Various in vitro studies have shown that TEGO® Cistus delivers strong anti-oxidative and anti-inflammatory effects, reduces reactive oxygen species (ROS) in skin cells and helps to protect the skin against external aggressions, such as UV light and pollution.
Extended in vivo studies have confirmed that TEGO® Cistus significantly protects the skin from UV induced inflammation and against oxidative stress.
Overall TEGO® Cistus is a natural based active ingredient with proven efficacy with highly scientific claim substantiation for sophisticated anti-ageing products.
Please find appropriate image data and further information on our Personal Care website: www.evonik.com/personal-care
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2011 more than 33,000 employees generated sales of around €14.5 billion and an operating profit (EBITDA) of about €2.8 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.